Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Blood Pressure Measurement | Research article

Diagnostic performance of clinic and home blood pressure measurements compared with ambulatory blood pressure: a systematic review and meta-analysis

Authors: Auttakiat Karnjanapiboonwong, Thunyarat Anothaisintawee, Usa Chaikledkaew, Charungthai Dejthevaporn, John Attia, Ammarin Thakkinstian

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Clinic blood pressure measurement (CBPM) is currently the most commonly used form of screening for hypertension, however it might have a problem detecting white coat hypertension (WCHT) and masked hypertension (MHT). Home blood pressure measurement (HBPM) may be an alternative, but its diagnostic performance is inconclusive relative to CBPM. Therefore, this systematic review aimed to estimate the performance of CBPM and HBPM compared with ambulatory blood pressure measurement(ABPM) and to pool prevalence of WCHT and MHT.

Methods

Medline, Scopus, Cochrane Central Register of Controlled Trials and WHO's International Clinical Trials Registry Platform databases were searched up to 23rd January 2020. Studies having diagnostic tests as CBPM or HBPM with reference standard as ABPM, reporting sensitivity and specificity of both tests and/or proportion of WCHT or MHT were eligible. Diagnostic performance of CBPM and HBPM were pooled using bivariate mixed-effect regression model. Random effect model was applied to pool prevalence of WCHT and MHT.

Results

Fifty-eight studies were eligible. Pooled sensitivity, specificity, and diagnostic odds ratio (DOR) of CBPM, when using 24-h ABPM as the reference standard, were 74% (95% CI: 65–82%), 79% (95% CI: 69%, 87%), and 11.11 (95% CI: 6.82, 14.20), respectively. Pooled prevalence of WCHT and MHT were 0.24 (95% CI 0.19, 0.29) and 0.29 (95% CI 0.20, 0.38). Pooled sensitivity, specificity, and DOR of HBPM were 71% (95% CI 61%, 80%), 82% (95% CI 77%, 87%), and 11.60 (95% CI 8.98, 15.13), respectively.

Conclusions

Diagnostic performances of HBPM were slightly higher than CBPM. However, the prevalence of MHT was high in negative CBPM and some persons with normal HBPM had elevated BP from 24-h ABPM. Therefore, ABPM is still necessary for confirming the diagnosis of HT.
Appendix
Available only for authorised users
Literature
1.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–104. PubMedCrossRef
2.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017;71(6):e13–115. PubMed
3.
Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D. White-coat hypertension and cardiovascular events: a meta-analysis. J Hypertens. 2016;34(4):593–9. PubMedCrossRef
4.
Huang Y, Huang W, Mai W, Cai X, An D, Liu Z, Huang H, Zeng J, Hu Y, Xu D. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017;35(4):677–88. PubMedPubMedCentralCrossRef
5.
Palla M, Saber H, Konda S, Briasoulis A. Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis. Integr Blood Pressure Control. 2018;11:11–24. CrossRef
6.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36(12):2284–309. PubMedCrossRef
7.
Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FD, Deeks JJ, Heneghan C, Roberts N, McManus RJ. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621. PubMedPubMedCentralCrossRef
8.
Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. preventive services task force. Ann Internal Med. 2015;162(3):192–204. CrossRef
9.
Conen D, Aeschbacher S, Thijs L, Li Y, Boggia J, Asayama K, Hansen TW, Kikuya M, Bjorklund-Bodegard K, Ohkubo T, et al. Age-specific differences between conventional and ambulatory daytime blood pressure values. Hypertension. 2014;64(5):1073–9. PubMedCrossRef
10.
Etyang AO, Warne B, Kapesa S, Munge K, Bauni E, Cruickshank JK, Smeeth L, Scott JA. Clinical and epidemiological implications of 24-hour ambulatory blood pressure monitoring for the diagnosis of hypertension in kenyan adults: a population-based study. J Am Heart Assoc. 2016;5:12. CrossRef
11.
Rhee MY, Kim SW, Choi EH, Kim JH, Nah DY, Shin SJ, Gu N. Prevalence of masked hypertension: a population-based survey in a large city by using 24-hour ambulatory blood pressure monitoring. Korean Circ J. 2016;46(5):681–7. PubMedPubMedCentralCrossRef
12.
Jaques H. National Institute for H, Clinical E: NICE guideline on hypertension. Eur Heart J. 2013;34(6):406–8. PubMed
13.
14.
Dixon DL, Salgado TM, Caldas LM, Van Tassell BW, Sisson EM: The, . American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists. J Am Pharm Assoc. 2017;2003:2018.
15.
de la Sierra A. Definition of white coat hypertension: ambulatory blood pressure, self-measured blood pressure, or both? Hypertension (Dallas, Tex: 1979). 2013;62(1):16–7. CrossRef
16.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. Group Q-: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36. PubMedCrossRef
17.
18.
Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–93. PubMedCrossRef
19.
Brueren MM, Dinant GJ, Schouten BJ, van Ree JW. Hypertension diagnosis by the family physician: measurements according to the NHG-standard (Dutch College of General Practitioners) compared with ambulatory blood pressure determination. Ned Tijdschr Geneeskd. 1995;139(6):278–82. PubMed
20.
Botomino A, Martina B, Ruf D, Bruppacher R, Hersberger KE. White coat effect and white coat hypertension in community pharmacy practice. Blood Press Monit. 2005;10(1):13–8. PubMedCrossRef
21.
Ungar A, Pepe G, Monami M, Lambertucci L, Torrini M, Baldasseroni S, Tarantini F, Marchionni N, Masotti G. Isolated ambulatory hypertension is common in outpatients referred to a hypertension centre. J Hum Hypertens. 2004;18(12):897–903. PubMedCrossRef
22.
Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508–15. PubMedCrossRef
23.
Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005;19(10):801–7. PubMedCrossRef
24.
Wang GL, Li Y, Staessen JA, Lu L, Wang JG. Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population. J Hypertens. 2007;25(12):2398–405. PubMedCrossRef
25.
Trudel X, Brisson C, Larocque B, Milot A. Masked hypertension: different blood pressure measurement methodology and risk factors in a working population. J Hypertens. 2009;27(8):1560–7. PubMedCrossRef
26.
Ishikawa J, Hoshide S, Eguchi K, Schwartz JE, Pickering TG, Shimada K, Kario K. Masked hypertension defined by ambulatory blood pressure monitoring is associated with an increased serum glucose level and urinary albumin-creatinine ratio. J Clin Hypertens (Greenwich). 2010;12(8):578–87. CrossRef
27.
Maseko MJ, Woodiwiss AJ, Majane OH, Molebatsi N, Norton GR. Marked underestimation of blood pressure control with conventional vs. ambulatory measurements in an urban, developing community of African ancestry. Am J Hypertens. 2011;24(7):789–95. PubMedCrossRef
28.
Afsar B. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension. J Cardiol. 2013;61(3):222–6. PubMedCrossRef
29.
Alwan H, Pruijm M, Ponte B, Ackermann D, Guessous I, Ehret G, Staessen JA, Asayama K, Vuistiner P, Younes SE, et al. Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH study. PLoS ONE. 2014;9(3):e92522. PubMedPubMedCentralCrossRef
30.
Al-Hashmi K, Al-Busaidi N, Amina B, Jaju D, Al-Waili K, Al-Rasadi K, Al-Sabti H, Al-Abri M. White coat hypertension and masked hypertension among omani patients attending a tertiary hospital for ambulatory blood pressure monitoring. Oman Med J. 2015;30(2):90–4. PubMedPubMedCentralCrossRef
31.
Mutlu S, Sari O, Arslan E, Aydogan U, Doganer YC, Koc B. Comparison of ambulatory blood pressure measurement with home, office and pharmacy measurements: is arterial blood pressure measured at pharmacy reliable? J Eval Clin Pract. 2016;22(1):40–5. PubMedCrossRef
32.
Scuteri A, Morrell CH, Orru M, AlGhatrif M, Saba PS, Terracciano A, Ferreli LA, Loi F, Marongiu M, Pilia MG, et al. Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study. Int J Cardiol. 2016;217:92–8. PubMedPubMedCentralCrossRef
33.
Melgarejo JD, Maestre GE, Thijs L, Asayama K, Boggia J, Casiglia E, Hansen TW, Imai Y, Jacobs L, Jeppesen J, et al. Prevalence, treatment, and control rates of conventional and ambulatory hypertension across 10 populations in 3 continents. Hypertension. 2017;70(1):50–8. PubMedCrossRef
34.
Fujita H, Matsuoka S, Awazu M. Masked isolated nocturnal hypertension in children and young adults. Pediatr Cardiol. 2018;39(1):66–70. PubMedCrossRef
35.
Hoegholm A, Kristensen KS, Bang LE, Gustavsen PH. White coat hypertension and blood pressure variability. Am J Hypertens. 1999;12(10):966–72. PubMedCrossRef
36.
Martinez MA, Garcia-Puig J, Martin JC, Guallar-Castillon P, Aguirre de Carcer A, Torre A, Armada E, Nevado A, Madero RS. Frequency and determinants of white coat hypertension in mild to moderate hypertension: a primary care-based study. Monitorizacion Ambulatoria de la Presion Arterial (MAPA)-Area 5 Working Group. Am J Hypertens. 1999;12(3):251–9. PubMedCrossRef
37.
Gan SK, Loh CY, Seet B. Hypertension in young adults–an under-estimated problem. Singapore Med J. 2003;44(9):448–52. PubMed
38.
Tunçkale A, Aran SN, Karpuz H, Dirican A. Relationship between insulin resistance and end-organ damage in white coat hypertension. Am J Hypertens. 2004;17(11):1011–6. PubMedCrossRef
39.
Shimbo D, Kuruvilla S, Haas D, Pickering TG, Schwartz JE, Gerin W. Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures. J Hypertens. 2009;27(9):1775–83. PubMedPubMedCentralCrossRef
40.
Berge HM, Andersen TE, Solberg EE, Steine K. High ambulatory blood pressure in male professional football players. Br J Sports Med. 2013;47(8):521–5. PubMedCrossRef
41.
Pengkeaw P, Suwannakarn S. Prevalence of hypertension in suspected hypertensive patients in Rajavithi Hospital using ambulatory blood pressure monitoring. J Med Assoc Thail. 2014;97(Suppl 11):S25-30.
42.
Mancia G, Facchetti R, Grassi G, Bombelli M. Adverse Prognostic value of persistent office blood pressure elevation in white coat hypertension. Hypertension. 2015;66(2):437–44. PubMedCrossRef
43.
Schoenthaler AM, Schwartz J, Cassells A, Tobin JN, Brondolo E. Daily interpersonal conflict predicts masked hypertension in an urban sample. Am J Hypertens. 2010;23(10):1082–8. PubMedCrossRef
44.
Viera AJ, Hinderliter AL, Kshirsagar AV, Fine J, Dominik R. Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. Am J Hypertens. 2010;23(11):1190–7. PubMedCrossRef
45.
Bacaksiz A, Erdogan E, Sonmez O, Sevgili E, Tasal A, Onsun N, Topukcu B, Kulac B, Uysal O, Goktekin O. Ambulatory blood pressure monitoring can unmask hypertension in patients with psoriasis vulgaris. Med Sci Monitor. 2013;19:501–9. CrossRef
46.
Sobrino J, Domenech M, Camafort M, Vinyoles E, Coca A. Prevalence of masked hypertension and associated factors in normotensive healthcare workers. Blood Press Monit. 2013;18(6):326–31. PubMedCrossRef
47.
Franklin SS, Thijs L, Li Y, Hansen TW, Boggia J, Liu Y, Asayama K, Bjorklund-Bodegard K, Ohkubo T, Jeppesen J, et al. Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension. 2013;61(5):964–71. PubMedCrossRef
48.
Larsen TR, Gelaye A, Waanbah B, Assad H, Daloul Y, Williams F, Williams M, Steigerwalt S. Prevalence of masked hypertension in African Americans. J Clin Hypertens (Greenwich). 2014;16(11):801–4. CrossRef
49.
Viera AJ, Lin FC, Tuttle LA, Shimbo D, Diaz KM, Olsson E, Stankevitz K, Hinderliter AL. Levels of office blood pressure and their operating characteristics for detecting masked hypertension based on ambulatory blood pressure monitoring. Am J Hypertens. 2015;28(1):42–9. PubMedCrossRef
50.
Trachsel LD, Carlen F, Brugger N, Seiler C, Wilhelm M. Masked hypertension and cardiac remodeling in middle-aged endurance athletes. J Hypertens. 2015;33(6):1276–83. PubMedCrossRef
51.
Redmond N, Booth JN 3rd, Tanner RM, Diaz KM, Abdalla M, Sims M, Muntner P, Shimbo D. Prevalence of masked hypertension and its association with subclinical cardiovascular disease in African Americans: results from the Jackson heart study. J Am Heart Assoc. 2016;5(3):e002284. PubMedPubMedCentralCrossRef
52.
Viera AJ, Lin FC, Tuttle LA, Olsson E, Girdler SS, Hinderliter AL. Examination of several physiological and psychosocial factors potentially associated with masked hypertension among low-risk adults. J Clin Hypertens (Greenwich). 2016;18(8):784–9. CrossRef
53.
Piantanida E, Gallo D, Veronesi G, Pariani N, Masiello E, Premoli P, Sassi L, Lai A, Tanda ML, Ferrario M, et al. Masked hypertension in newly diagnosed hypothyroidism: a pilot study. J Endocrinol Invest. 2016;39(10):1131–8. PubMedCrossRef
54.
Booth JN 3rd, Muntner P, Diaz KM, Viera AJ, Bello NA, Schwartz JE, Shimbo D. Evaluation of criteria to detect masked hypertension. J Clin Hypertens (Greenwich). 2016;18(11):1086–94. CrossRef
55.
Anstey DE, Booth JN, Abdalla M, Spruill TM, Min YI, Muntner P, Shimbo D. Predicted atherosclerotic cardiovascular disease risk and masked hypertension among blacks in the Jackson heart Study. Circul Cardiovasc Qual Outcomes. 2017;10:7. CrossRef
56.
Ozkan S, Ata N, Yavuz B. Increased masked hypertension prevalence in patients with obesity. Clin Exp Hypertens (New York, NY). 2018;2018:1–4.
57.
Gun T, Ozkan S, Yavuz B. Is tinnitus an early voice of masked hypertension? High masked hypertension rate in patients with tinnitus. Clin Exp Hypertens (New York, NY). 2018;2018:1–4.
58.
Bhattarai M, Sainju NK, Bhandari B, Kc V, Karki DB. Prevalence of white coat hypertension among the patients visiting in a tertiary care center, Kathmandu, Nepal. Kathmandu Univ Med J. 2019;17(66):119–22.
59.
Cai P, Peng Y, Chen Y, Li L, Chu W, Wang Y, Wang X. Association of thyroid function with white coat hypertension and sustained hypertension. J Clin Hypertens (Greenwich, Conn). 2019;21(5):674–83. CrossRef
60.
Calvo-Vargas C, Padilla-Rios V, Troyo-Sanromán R. Loaned self-measurement equipment model compared with ambulatory blood pressure monitoring. Blood Pressure Monit. 2003;8(2):63–70. CrossRef
61.
Erdogmus S, Kutlay S, Celebi ZK, Aydin T, Ors Sendogan D, Kumru G, Keven K, Nergizoglu G, Erturk S, Sengul S. Clinical correlates of ambulatory blood pressure phenotypes at a tertiary care hospital in Turkey. Kidney Blood Pressure Res. 2018;43(3):690–700. CrossRef
62.
Kaul U, Arambam P, Rao S, Kapoor S, Swahney JPS, Sharma K, Nair T, Chopda M, Hiremath J, Ponde CK, et al. Usefulness of ambulatory blood pressure measurement for hypertension management in India: the India ABPM study. J Hum Hypertens. 2019;71:91.
63.
Michaud A, Lamarre-Cliche M, Cloutier L. Screening for hypertension: An elevated office blood pressure measurement is valuable, adding an automated one is even better. Blood Pressure Monit. 2019;24(3):123–9. CrossRef
64.
Salazar MR, Espeche WG, Balbin E, Leiva Sisnieguez CE, Minetto J, Leiva Sisnieguez BC, Maciel PM, Stavile RN, Carbajal HA. Prevalence of isolated nocturnal hypertension according to 2018 European Society of Cardiology and European Society of Hypertension office blood pressure categories. J Hypertens. 2019;6:914.
65.
Sheppard JP, Martin U, Gill P, Stevens R, Hobbs FR, Mant J, Godwin M, Hanley J, McKinstry B, Myers M, et al. Prospective external validation of the Predicting Out-of-OFfice Blood Pressure (PROOF-BP) strategy for triaging ambulatory monitoring in the diagnosis and management of hypertension: observational cohort study. BMJ (Clinical research ed). 2018;361:k2478. CrossRef
66.
Trudel X, Brisson C, Gilbert-Ouimet M, Vezina M, Talbot D, Milot A. Long working hours and the prevalence of masked and sustained hypertension. Hypertension. 2020;75(2):532–8. PubMedCrossRef
67.
Almeida AE, Stein R, Gus M, Nascimento JA, Arevalo JR, Fuchs FD, Ribeiro JP. Improved diagnostic accuracy of a 3-day protocol of home blood pressure monitoring for the diagnosis of arterial hypertension. Blood Pressure Monit. 2013;18(2):119–26. CrossRef
68.
Park JS, Rhee MY, Namgung J, Lee SY, Cho DK, Choi TY, Kim SY, Kim JY, Park SM, Choi JH, et al. Comparison of optimal diagnostic thresholds of hypertension with home blood pressure monitoring and 24-hour ambulatory blood pressure monitoring. Am J Hypertens. 2017;30(12):1170–6. PubMedCrossRef
69.
de Almeida AEM, Stein R, Gus M, Nascimento JA, Belli KC, Arévalo JRG, Fuchs FD, Ribeiro JP. Relevance to home blood pressure monitoring protocol of blood pressure measurements taken before first-morning micturition and in the afternoon. Arq Bras Cardiol. 2014;103(4):338–47. PubMedPubMedCentral
70.
Rhee MY, Kim JY, Kim JH, Namgung J, Lee SY, Cho DK, Choi TY, Kim SY. Optimal schedule of home blood-pressure measurements for the diagnosis of hypertension. Hypertens Res. 2018;41(9):738–47. PubMedCrossRef
71.
Zhang L, Li Y, Wei FF, Thijs L, Kang YY, Wang S, Xu TY, Wang JG, Staessen JA. Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement. Hypertension. 2015;65(6):1258–65. PubMedCrossRef
72.
Hanninen MR, Niiranen TJ, Puukka PJ, Jula AM. Comparison of home and ambulatory blood pressure measurement in the diagnosis of masked hypertension. J Hypertens. 2010;28(4):709–14. PubMedCrossRef
73.
Stergiou GS, Skeva II, Baibas NM, Kalkana CB, Roussias LG, Mountokalakis TD. Diagnosis of hypertension using home or ambulatory blood pressure monitoring: comparison with the conventional strategy based on repeated clinic blood pressure measurements. J Hypertens. 2000;18(12):1745–51. PubMedCrossRef
74.
Ntineri A, Niiranen TJ, McManus RJ, Lindroos A, Jula A, Schwartz C, Kollias A, Andreadis EA, Stergiou GS. Ambulatory versus home blood pressure monitoring: frequency and determinants of blood pressure difference and diagnostic disagreement. J Hypertens. 2019;37(10):1974–81. PubMedCrossRef
75.
Franklin SS, Thijs L, Hansen TW, O’Brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension (Dallas, Tex: 1979). 2013;62(6):982–7. CrossRef
76.
Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, Imai Y, Ohkubo T, Kario K. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension (Dallas, Tex: 1979). 2005;45(2):203–8. CrossRef
77.
Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, Boggia J, Johansson JK, Ohkubo T, Tsuji I, et al. Prognosis of white-coat and masked hypertension: international database of home blood pressure in relation to cardiovascular outcome. Hypertension. 2014;63(4):675–82. PubMedCrossRef
78.
Schmucker CM, Blümle A, Schell LK, Schwarzer G, Oeller P, Cabrera L, von Elm E, Briel M, Meerpohl JJ. on behalf of the Oc: Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical research. PLoS ONE. 2017;12(4):e0176210. PubMedPubMedCentralCrossRef
79.
Fergusson D, Laupacis A, Salmi LR, McAlister FA, Huet C. What should be included in meta-analyses? An exploration of methodological issues using the ISPOT meta-analyses. Int J Technol Assess Health Care. 2000;16(4):1109–19. PubMedCrossRef
Metadata
Title
Diagnostic performance of clinic and home blood pressure measurements compared with ambulatory blood pressure: a systematic review and meta-analysis
Authors
Auttakiat Karnjanapiboonwong
Thunyarat Anothaisintawee
Usa Chaikledkaew
Charungthai Dejthevaporn
John Attia
Ammarin Thakkinstian
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01736-2

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue

Research article

Differential leukocyte counts and cardiovascular mortality in very old patients with acute myocardial infarction: a Chinese cohort study

Study protocol

Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial

Research article

Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012–2018)

Case report

Acute peripheral pulmonary embolism attributed to autoimmune haemolytic anaemia: a case report

Research article

Assessment of successful percutaneous mitral commissurotomy by MRproANP and sCD146

Research article

Comparison of the effect of membrane sizes and fibre arrangements of two membrane oxygenators on the inflammatory response, oxygenation and decarboxylation in a rat model of extracorporeal membrane oxygenation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits